Log inSign up
AAOIFI No. 21 screening

Is SNY halal?

Sanofi

Not halal

Sanofi did not pass AAOIFI screening. The failed check is shown below.

Checked: 13 October 2026

Exchange

NASDAQ

Price

40.61

Day

+0.79%

Market cap

$95.22B

Industry

Drug Manufacturers - General

Sector

Healthcare

What the company does

Sanofi (France) is a drugmaker: Dupixent (eczema/asthma, its main drug), vaccines (flu and others), rare-disease drugs and insulin. Revenue comes from drug and vaccine sales.

What was checked

The AAOIFI standard has four steps: business activity first, then three financial ratios. Fail one and the stock is not halal.

  • Business activity

    No prohibited activity

  • Interest-bearing debt / market cap

    limit 30%

    Interest-bearing debt $26.39B ÷ 36-month average market cap $61.27B = 43.1%

    43.1%

    Fail

  • Cash & investments / market cap

    limit 30%

    Cash + interest-bearing securities $10.24B ÷ 36-month average market cap $61.27B = 16.7%

    16.7%

    Pass

  • Non-compliant income / total revenue

    limit 5%

    Interest income $370.49M ÷ annual revenue $52.29B (2025) = 0.7%

    0.7%

    Pass

Figures from the company's filings (2026-06-30), USD. Market cap is a 36-month average (the S&P Shariah index approach), so a one-day price move does not flip the verdict. Today's market cap: $95.22B.

For information (AAOIFI 3/1 note): cash + receivables are 5.3% of total assets (2026-06-30). AAOIFI recommends tangible assets of at least one third — this figure does not affect the verdict, and other major screeners do not apply it either.

In the lists

In the S&P 500
Not in the S&P 500
Held by funds
SPWO 0.41%

Superinvestors

SEC 13F, 2026 Q3. Up to 45 days delayed.

Held by 4 superinvestors · Average reported price: $42.66

All superinvestor portfolios

Halal stocks in the same industry

The largest halal stocks in Drug Manufacturers - General — for comparison.

Related articles

Halal is the first question. The second: when to enter?

Our scanner watches 1454 halal stocks around the clock and fires a signal with entry, TP and SL when a technical setup completes. The full signal history — with outcomes — is public.

This is neither investment advice nor a fatwa. Screening is based on public financial statements and AAOIFI standard No. 21; data may lag. For a personal decision consult your own scholar.

Earnings historySNY's next report date, EPS estimate vs actual for recent quarters and the post-earnings price move.View earnings →